The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
No Access

Kinetic constants of platelet monoamine oxidase in schizophrenia

Published Online:https://doi.org/10.1176/ajp.140.8.1044

It has been reported that one or both of the kinetic constants (Km and Vmax) of monoamine oxidase (MAO) in the blood platelets of schizophrenic patients are significantly lower than those of normal controls. The authors found no significant differences in Km or Vmax of platelet MAO activity between schizophrenic patients, schizoaffective depressed, mainly schizophrenic patients, and normal control subjects of the same sex. There was also no relationship between paranoid symptoms, hallucinations, or a family history of schizophrenia and Vmax or Km of platelet MAO in the combined groups of schizophrenic and schizoaffective patients. Women had significantly higher Vmax values, but no sex difference in Km was noted.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.